PAMA is here


Pama is here:
Navigating Change and Aligning
your Organization for Success


Charles Root, PhD | CEO, CodeMap LLC
Peter Kelly | Divisional VP, Abbott


Representing the most significant clinical lab payment reform in over 30 years, the new Protecting Access to Medicare Act (PAMA) reimbursement rates became effective January 1, 2018.

Under PAMA, laboratory organizations will see a change in reimbursement paid for the highest volume lab tests under Medicare Part B. This includes Hospital Outpatient, Reference Labs, Independent Labs, Physician Offices, Ambulatory Surgery Centers, Long Term Cares, and all other outpatient facilities performing lab tests. In addition, Point of care testing will also experience different reimbursement rates due to the elimination of Automated Test Panels. With a heightened demand for financial discipline, labs will be empowered by a better understanding of their facility’s financial data, associated costs and payments, and overall strategy developed for sustainable business.

This webinar will describe the reimbursement environment leading to PAMA, identify PAMA payment impact for Medicare Part B (outpatient) lab services, discuss how the elimination of automated test panels (ATP) codes will affect reimbursement, and review how specific point of care assays are impacted by the new payment rates.

learning Objectives

  1. Describe the reimbursement environment leading to PAMA
  2. Identify PAMA payment impact for Medicare Part B (outpatient) lab services
  3. Discuss how the elimination of automated test panels (ATP) codes will affect reimbursement
  4. Review how specific point of care assays are impacted by the new payment rates
Continuing Education

One P.A.C.E.® contact hour will be provided for this basic level
session until September 21st, 2018. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563
This event is produced by Whitehat Communications and sponsored
by Abbott Point of Care.

Access Webinar


ABOUT Charles Root, PhD

DrRoot.jpgCEO, CodeMap LLC
Dr Root has provided laboratory coding and reimbursement information to healthcare providers and manufacturers for over 20 years regarding compliance, coding and economic issues. CodeMap’s clients include more than 35 diagnostic test manufacturers and over 1500 providers who rely on CodeMap publications, compliance training, and advisory services. Dr. Root is a member of the American Association of Clinical Chemists and serves on their Government Relations Committee. He provides frequent input and comments to CMS on laboratory issues.


ABOUT peter Kelly

PKelly.jpgDivisional VP, Abbott 
Peter Kelly is the Divisional Vice President of Corporate Reimbursement and Strategic Initiatives for the Government Affairs function at Abbott. Peter is responsible for ensuring positive reimbursement decisions for Abbott products in Medicare and Medicaid, and so leads coding, coverage and payment strategies aimed at broad patient access through these federal and state health care programs. Additionally, he develops initiatives and partnerships to support government affairs and alliance development activities around the world.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

Not optimized for your device

The page you are trying to access is best viewed on a desktop or laptop computer.

I want to view this page anyway
Contact us today